Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
Diamanti
Antonella
A
Papadatou
Bronislava
B
Knafelz
Daniela
D
Gambarara
Manuela
M
Ferretti
Francesca
F
Castro
Massimo
M
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D013997:Time Factors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab